Inivata
Latest round
- Series C
Last raised
- Feb 2021
Total raised
- $139M
Investors
- 9
About Inivata
Based in Cambridge, United Kingdom, and founded in 2014, Inivata Ltd. is a developer of liquid biopsy. The company was co-founded by Clive Morris, Davina Gale, James Brenton, Nitzan Rosenfeld, and Tim Forshew. Inivata Ltd. has a CLIA certified, CAP-accredited laboratory in Research Triangle Park, NC, and Research Development (R&D) laboratories in Cambridge, UK. In 2016, the company won a One Nucleus BioNewsRound Award at Genesis Conference. In February 2021, Inivata Ltd. In May 2021, the company was acquired by NeoGenomics, Inc. Inivata operates as a liquid biopsy platform that offers Non-invasive ctDNA analysis for describing the process of extracting a small blood sample from a patient, Circulating Tumor DNA intended to represent the release of ctDNA into the bloodstream by a tumor, and Radar for the detection of residual disease and recurrence. The company provides InVisionFirst-Lung, a genomic test administered using blood plasma from Non-Small Cell Lung Cancer (NSCLC) patients, and InVisionSeq, another genomic sequencing test. Inivata Ltd. In addition, the proceeds will drive the continued commercial rollout of Inivata’s InVisionFirst®-Lung liquid biopsy test.
Who invested in Inivata
9 investors across 4 rounds
See all investors in Inivata
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inivata
Who invested in Inivata?
Inivata has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inivata raised?
Inivata has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Inivata last raise money?
Inivata's most recent round on record is a Series C, in Feb 2021.
What does Inivata do?
Based in Cambridge, United Kingdom, and founded in 2014, Inivata Ltd.
Where is Inivata headquartered?
Inivata is headquartered in Cambridge, UK.
Which VCs invest in companies like Inivata?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Inivata's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Inivata? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.